Balanced news tone
News Sentiment
MAP sentiment intelligence
Microba Life Sciences Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
85/100 classification confidence.
directly relevant articles
high-authority source matches
+5.1% over one week, -10.9% over four weeks, trend inactive, and below fair value.
Earnings call transcript: Microba Life Sciences posts strong FY26 growth in Q4 2026
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Earnings call transcript: Microba Life Sciences posts strong FY26 growth in Q4 2026
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 16 Jul 2026 07:25
- Source
- Investing.com UK
Microba Life Sciences Posts 92% Core Testing Revenue Growth in FY26, Eyes September Launch of GI Navigator Product
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 15 Jul 2026 23:53
- Source
- Kalkine
Microba Life Sciences (ASX: MAP): Substantial Holder Steps Aside as Placement Reshapes the Register
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Kalkine
Danaher Stock - long-term strategy in life sciences
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 07:00
- Source
- Ad Hoc News
Kalkine Stock Analysis: Microba Life Sciences (ASX:MAP): Can New Funding Drive Next Phase of Growth?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- Kalkine
Kalkine Market Watch: Can Microba Life Sciences (ASX:MAP) Recover from Its Recent Decline?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- Kalkine
Can Microba’s Trading Halt Signal A Key Turning Point?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Kalkine Media
Insiders In Microba Life Sciences Left Out From 13% Price Rise After Disposing Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2026 07:00
- Source
- simplywall.st
Microba Life Sciences Raises AUD 14.5 Million, Updates Guidance and Signs UK Deal
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 23 Jun 2025 07:00
- Source
- Kalkine
Microba Life Sciences Ltd (ASX: MAP) Share Price, MAP Stock News, MAP Share Price & Updates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Dec 2024 08:39
- Source
- Kalkine
Microba Commences Phase I Clinical Trial for IBD Therapeutic
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2023 07:00
- Source
- 뉴스와이어
Sonic Healthcare acquires 20% stake in Microba Life Sciences
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 29 Nov 2022 08:00
- Source
- smallcaps.com.au
Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 28 Nov 2022 08:00
- Source
- Business Wire
MAP Stock Price and Chart — ASX:MAP
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2022 15:10
- Source
- TradingView
Microba Life Sciences Limited (ASX: MAP) - Share Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Apr 2022 12:53
- Source
- intelligentinvestor.com.au
Microba Life Sciences Limited (ASX: MAP) - Announcements
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Apr 2022 01:41
- Source
- intelligentinvestor.com.au
Microba Life Sciences Limited (ASX:MAP)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Apr 2022 22:39
- Source
- intelligentinvestor.com.au